Horan Capital Advisors’s Biogen BIIB Stock Holding History

Horan Capital Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-202	Closed	-$57K	–	106
2020 Q3	$57K	Buy	+202	New	+$56.3K	0.03%	164
2020 Q1	–	Sell	-202	Closed	-$60K	–	91
2019 Q4	$60K	Hold	202	–	–	0.04%	136
2019 Q3	$47K	Buy	+202	New	+$47K	0.03%	145
2019 Q2	–	Sell	-342	Closed	-$81K	–	90
2019 Q1	$81K	Buy	+342	New	+$108K	0.05%	115
2017 Q4	–	Sell	-410	Closed	-$128K	–	90
2017 Q3	$128K	Buy	+410	New	+$121K	0.08%	92
2014 Q3	–	Sell	-2,211	Closed	-$697K	–	59
2014 Q2	$697K	Buy	2,211 +40	+2%	+$12K	0.64%	48
2014 Q1	$664K	Hold	2,171	–	–	0.64%	48
2013 Q4	$607K	Buy	2,171 +154	+8%	+$39.8K	0.62%	50
2013 Q3	$486K	Buy	+2,017	New	+$451K	0.58%	48

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Horan Capital Advisors's BIIB Position: Q4 2020 in Review

Horan Capital Advisors sold out of Biogen (BIIB) in Q4 2020, closing a stake of 202 shares — an estimated $57K sold.

Horan Capital Advisors first reported a position in BIIB in Q3 2013 and held it in 9 quarters. The position peaked at $697K in Q2 2014. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

Horan Capital Advisors reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
Horan Capital Advisors sold 202 Biogen shares in Q4 2020, an estimated $57K.
Horan Capital Advisors first reported a position in Biogen in Q3 2013 and held it in 9 quarters.
Horan Capital Advisors's Biogen position peaked at $697K in Q2 2014.
1,062 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Horan Capital Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.